New gene therapy aims to boost immune attack on prostate cancer
NCT ID NCT07332000
Summary
This study is testing a new gene therapy approach for men with intermediate-risk prostate cancer who are scheduled for radiation treatment. The therapy involves injecting a modified virus into the prostate, followed by taking an oral antiviral pill, to try to kill cancer cells and stimulate the body's immune system. Researchers will primarily track where the therapy goes in the body and measure immune system changes to understand how it works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chesapeake Urology Research Associates
RECRUITINGTowson, Maryland, 21204, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START Carolinas
RECRUITINGMyrtle Beach, South Carolina, 29572, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sheldon Freedman, MD Ltd.
RECRUITINGLas Vegas, Nevada, 89144, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Summit Health
RECRUITINGSaddle Brook, New Jersey, 07663, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.